‘An Arm and a Leg’: The New Cap on Medicare Drug Costs


Can’t see the audio participant? Click here to listen.

Click here for a transcript of the episode.


On a Sunday afternoon in August, well being providers researcher Stacie Dusetzina was sitting alone in her workplace at Vanderbilt College, watching C-SPAN and crying.

The U.S. Senate was voting on the Inflation Discount Act, which amongst different issues is designed to make sure that folks on Medicare pay much less for costly medication.

It’s a giant deal. A lot of seniors pay $10,000 a yr or extra for medication or do with out lifesaving remedy; as soon as the brand new regulation kicks in, it units an out-of-pocket restrict of $2,000 a yr. 

Dusetzina and her colleagues have spent years making the case for this transformation, documenting the methods present insurance policies go away folks within the lurch. 

The pharmaceutical trade fought this transformation tooth and nail — for many years. Julie Rovner, chief Washington correspondent for KHN, takes listeners on a journey again to the late Eighties, when Congress realized the price of messing with Massive Pharma. 


“An Arm and a Leg” is a co-production of KHN and Public Street Productions.

To communicate with “An Arm and a Leg,” subscribe to the newsletter. It’s also possible to observe the present on Facebook and Twitter. And if you happen to’ve received tales to inform concerning the well being care system, the producers would love to hear from you.

To listen to all KHN podcasts, click here.

And subscribe to “An Arm and a Leg” on Spotify, Apple Podcasts, StitcherPocket Casts, or wherever you take heed to podcasts.

Source

Leave a Reply

Your email address will not be published.